Key takeaways: The FDA has approved the world’s first vaccine for Respiratory Syncytial Virus (RSV) for adults aged 60 and up, made by GSK. The…
Posts tagged as “the Food and Drug Administration”
Key takeaways: The Supreme Court has paused lower court rulings that would have imposed restrictions on mifepristone. This ruling keeps the drug accessible while the…
The Supreme Court has granted the Justice Department's request to leave in place the FDA's approval of the widely used abortion pill mifepristone, preserving access to the drug and reinstating steps that make it easier to obtain. This decision is a victory for abortion rights advocates, who argued that the restrictions on the drug were medically unnecessary. The case is expected to be heard by the full 5th Circuit Court of Appeals in the coming months.
A federal judge in West Virginia has denied a request from Republican officials to pause a lawsuit from a maker of mifepristone. U.S. District Judge Matthew Kacsmaryk, a Trump appointee, had failed to disclose two interviews on a Christian radio show where he discussed his extremist views on contraception and gay rights. The case is now pending at the Fourth Circuit Court of Appeals, and questions have been raised about Kacsmaryk's impartiality and ability to make unbiased rulings.
The Supreme Court has granted a temporary extension of access to the abortion pill mifepristone until Friday while they consider a legal challenge to the medication's FDA approval. The lower court ruling had increased the gestational age limit for using the drug and reduced the number of required in-person visits. The Biden administration and drug maker Danco Laboratories have requested the Supreme Court to halt the appeals court ruling. The temporary extension of access to mifepristone will remain in place until Friday at 11:59 p.m.
The Supreme Court is expected to make a decision Wednesday on a request by the federal government to immediately block a lower court ruling that would restrict access to the abortion pill mifepristone. The case originated in Judge Matthew Kacsmaryk’s court in Amarillo, Texas, and the outcome of this decision could have a major impact on access to mifepristone and the ability of women to make decisions about their own reproductive health. The Department of Justice has appealed to the Fifth Circuit Court of Appeals and the Supreme Court has temporarily blocked the appeals court ruling while the justices consider what next steps to take.
The FDA has authorized a second dose of the updated Covid booster for older adults and people with weakened immune systems, which is designed to protect against the BA.4 and BA.5 variants of Omicron. This new bivalent formula will replace the multi-dose primary series for those who have not yet been vaccinated, and can be administered as early as four months after the first shot. It is hoped that this will help to reduce the spread of the virus and protect those who are most vulnerable.
The Supreme Court has temporarily blocked a ruling from a federal judge in Texas that would have put a pause on the Food and Drug Administration's approval of mifepristone, a medicine used in two-step medication abortions. This decision will allow for nationwide access to mifepristone to be preserved until Wednesday, when the justices will consider next steps. Abortion clinics are readying contingency plans in case mifepristone's FDA approval is overturned.